These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15006143)

  • 1. A strategy for discovery of novel broad-spectrum antibacterials using a high-throughput Streptococcus pneumoniae transcription/translation screen.
    Pratt SD; David CA; Black-Schaefer C; Dandliker PJ; Xuei X; Warrior U; Burns DJ; Zhong P; Cao Z; Saiki AY; Lerner CG; Chovan LE; Soni NB; Nilius AM; Wagenaar FL; Merta PJ; Traphagen LM; Beutel BA
    J Biomol Screen; 2004 Feb; 9(1):3-11. PubMed ID: 15006143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glycopeptide vancomycin does not enhance toll-like receptor 2 (TLR2) activation by Streptococcus pneumoniae.
    Moore LJ; Pridmore AC; Dower SK; Read RC
    J Antimicrob Chemother; 2004 Jul; 54(1):76-8. PubMed ID: 15190028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization.
    Miller JR; Herberg JT; Tomilo M; McCroskey MC; Feilmeier BJ
    Anal Biochem; 2007 Jun; 365(1):132-43. PubMed ID: 17395144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel dihydrofolate reductase inhibitors. Structure-based versus diversity-based library design and high-throughput synthesis and screening.
    Wyss PC; Gerber P; Hartman PG; Hubschwerlen C; Locher H; Marty HP; Stahl M
    J Med Chem; 2003 Jun; 46(12):2304-12. PubMed ID: 12773035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on antibacterial activity of pheromonicin-SP].
    Qin Y; Zhang J; Dai P; Sun L; Qiu XQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):109-12. PubMed ID: 17294741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation for high-throughput screening of a VanRS-based reporter gene assay for bacterial cell wall inhibitors.
    De Pascale G; Grigoriadou C; Losi D; Ciciliato I; Sosio M; Donadio S
    J Appl Microbiol; 2007 Jul; 103(1):133-40. PubMed ID: 17584459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway.
    Sangvik M; Littauer P; Simonsen GS; Sundsfjord A; Dahl KH
    J Antimicrob Chemother; 2005 Nov; 56(5):841-6. PubMed ID: 16172106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation, structure, and antibacterial activity of phaeosphenone from a Phaeosphaeria sp. discovered by antisense strategy.
    Zhang C; Ondeyka JG; Zink DL; Basilio A; Vicente F; Collado J; Platas G; Bills G; Huber J; Dorso K; Motyl M; Byrne K; Singh SB
    J Nat Prod; 2008 Jul; 71(7):1304-7. PubMed ID: 18570471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and initial development of a novel class of antibacterials: inhibitors of Staphylococcus aureus transcription/translation.
    Larsen SD; Hester MR; Craig Ruble J; Kamilar GM; Romero DL; Wakefield B; Melchior EP; Sweeney MT; Marotti KR
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6173-7. PubMed ID: 17027262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation frequency in antibiotic-resistant and -susceptible isolates of Streptococcus pneumoniae.
    Henderson-Begg SK; Sheppard CL; George RC; Livermore DM; Hall LM
    Int J Antimicrob Agents; 2010 Apr; 35(4):342-6. PubMed ID: 20149603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of vancomycin tolerance in Streptococcus pneumoniae.
    Novak R; Henriques B; Charpentier E; Normark S; Tuomanen E
    Nature; 1999 Jun; 399(6736):590-3. PubMed ID: 10376600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AG205, a novel agent directed against FabK of Streptococcus pneumoniae.
    Takahata S; Iida M; Osaki Y; Saito J; Kitagawa H; Ozawa T; Yoshida T; Hoshiko S
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2869-71. PubMed ID: 16870790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
    Rodríguez-Cerrato V; García P; Del Prado G; García E; Gracia M; Huelves L; Ponte C; López R; Soriano F
    J Antimicrob Chemother; 2007 Nov; 60(5):1159-62. PubMed ID: 17827138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of DW286 against Streptococcus pneumoniae.
    Park HS; Jung SJ; Choi DR; Kwak JH
    Int J Antimicrob Agents; 2010 Sep; 36(3):230-3. PubMed ID: 20627463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plectasin has antibacterial activity and no affect on cell viability or IL-8 production.
    Hara S; Mukae H; Sakamoto N; Ishimoto H; Amenomori M; Fujita H; Ishimatsu Y; Yanagihara K; Kohno S
    Biochem Biophys Res Commun; 2008 Oct; 374(4):709-13. PubMed ID: 18675251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel synthetic molecules targeting the bacterial RNA polymerase assembly.
    André E; Bastide L; Michaux-Charachon S; Gouby A; Villain-Guillot P; Latouche J; Bouchet A; Gualtiéri M; Leonetti JP
    J Antimicrob Chemother; 2006 Feb; 57(2):245-51. PubMed ID: 16373430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel antibacterial class.
    Dandliker PJ; Pratt SD; Nilius AM; Black-Schaefer C; Ruan X; Towne DL; Clark RF; Englund EE; Wagner R; Weitzberg M; Chovan LE; Hickman RK; Daly MM; Kakavas S; Zhong P; Cao Z; David CA; Xuei X; Lerner CG; Soni NB; Bui M; Shen LL; Cai Y; Merta PJ; Saiki AY; Beutel BA
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3831-9. PubMed ID: 14638491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity of putative Tn5253-like elements in Streptococcus pneumoniae.
    Henderson-Begg SK; Roberts AP; Hall LM
    Int J Antimicrob Agents; 2009 Apr; 33(4):364-7. PubMed ID: 19097761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neopyrrolomycins with broad spectrum antibacterial activity.
    Hopp DC; Rhea J; Jacobsen D; Romari K; Smith C; Rabenstein J; Irigoyen M; Clarke M; Francis L; Luche M; Carr GJ; Mocek U
    J Nat Prod; 2009 Feb; 72(2):276-9. PubMed ID: 19191549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.